Slide Insurance (SLDE) CEO-linked entity pre-plans 184,817-share sale, retains large stake
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported an indirect open-market sale of common stock by IIM Holdings II, LLC, an entity he controls. The entity sold 184,817 shares at a weighted average price of $18.78 per share under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, IIM Holdings II, LLC held 34,971,348 shares of Slide Insurance common stock. The filing also shows Bruce’s indirect holdings through irrevocable trusts and his spouse, and direct ownership of 1,151,445 shares, with all such positions reported with standard beneficial ownership disclaimers.
Positive
- None.
Negative
- None.
Insights
CEO-linked entity executes pre-planned sale while retaining a large position.
The filing shows an indirect sale of 184,817 Slide Insurance shares at a weighted average of $18.78 by IIM Holdings II, LLC, which is controlled by CEO Lucas Bruce. A footnote states the trades were made under a Rule 10b5-1 trading plan adopted on November 21, 2025, indicating they were pre-scheduled.
Following the sale, IIM Holdings II, LLC still held 34,971,348 shares, and Bruce reports additional direct and indirect holdings via trusts and his spouse. The scale of the remaining position and the pre-planned nature of the sale suggest a routine liquidity event rather than a directional change in exposure, based solely on this filing.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 184,817 | $18.78 | $3.47M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $18.84 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 18,279 shares of common stock on May 20, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.75 to $18.84 per share. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.